# Tony Kulesa

> Tony Kulesa is a seed investor at Petri backing Biotechnology and Energy. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Petri](https://shizune.co/investors/profile/petri-bio)
- Total investments: 2
- Last investment: Dec 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/tony-kulesa/

Tony Kulesa is a seed investor at Petri focused on Biotechnology and Energy. Tony Kulesa

## Contacts

5 contacts available for Tony Kulesa: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/tony-kulesa-f829?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Energy | 1 | 50% |
| Medical | 1 | 50% |
| Chemical | 1 | 50% |
| Pharmaceutical | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Pre-Seed | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rowan | Rowan is a molecular design and simulation tool that is often used by scientists, particularly in fields like chemistry, material science, and drug discovery. It provides an environment for simulating molecular structures and predicting their behavior under various conditions. | $2.1M | Pre-Seed | Dec 09, 2024 |  |
| New Equilibrium Biosciences | New Equilibrium Biosciences provides a platform that reveals opportunities for structure-based design by learning biophysics with AI. | $10M | Seed | Mar 31, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [AI Grant](https://shizune.co/investors/profile/ai-grant) — VC Fund, 1 deal together
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund, 1 deal together

## About Petri

VC Fund · Boston, United States

Petri is a new approach for funding formation-stage startups at the intersection of biology and engineering. Petri is co-founded by entrepreneurs who have built iconic companies as well as academics who are driving foundational science in bioengineering; together we have deep experience developing ideas into successful companies across humanhealth and sustainability.We invest pre-seed and seed capital and work one-on-one with founders for 12+ months. We help founders build world-class teams, develop intellectual property, find customers, and raise a subsequent round of financing.

5 contacts available at Petri.

| Name | Title | Profile |
| --- | --- | --- |
| Brian Baynes | Founder | — |
| Jamie Goldstein | Founder and Chairman | https://shizune.co/investors/profile/jamie-goldstein |
| Jaye Goldstein | Head of Program | — |
| Josh Moser | Partner | — |
| Tony Kulesa | Founder, Partner | — |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Tony Kulesa invest in?

Tony Kulesa invests primarily in Biotechnology, Energy and Medical startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Tony Kulesa?

Public channels for Tony Kulesa include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Tony Kulesa last invest?

The most recent investment recorded for Tony Kulesa closed in Dec 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co